Innovative Vitality expands menopause care in Chicago and Illinois

Innovative Vitality is launching a menopause clinic in Chicago to address widespread gaps in care, using Menopause Society guidance, longer visits and personalized treatment plans. The practice says the goal is to help women across Illinois access evidence-based care for symptoms that many patients still struggle to discuss or treat.

Why it matters: - Menopause care remains undersupplied, even though every woman will experience menopause. - The Gallup-Pivotal Women's Health Survey found that only 25% of U.S. women say they understand menopause treatment options well. - Fewer than half of women, or 44%, have ever discussed menopause with a healthcare provider. - About one in four women who sought treatment, or 24%, had to push to be taken seriously. - Innovative Vitality is aiming to fill that gap with personalized, science-based care for women who have felt dismissed in medicine.

What happened: - Innovative Vitality, a Chicago-based medical practice, is offering a menopause clinic for women in perimenopause, menopause and postmenopause. - The clinic follows guidance from The Menopause Society and uses Menopause Society Certified Practitioners. - Care is available in person in Chicago and by telehealth across Illinois. - Women can book a discovery call at more information or learn more at menopause care details.

The details: - The Gallup-Pivotal survey covered 3,845 U.S. women. - Women heard about menopause more often from family, at 61%, and friends, at 59%, than from doctors, at 51%. - Among women who sought treatment, 23% saw multiple providers before symptoms were addressed. - Another 20% could not get the care they needed despite trying. - A Mayo Clinic study of nearly 5,000 women ages 45 to 60 found that 87% did not seek medical care for menopause symptoms. - In that study, 34% reported moderate to very severe symptoms. - In November 2025, the U.S. Food and Drug Administration removed the black box warning from most menopausal hormone therapy products. - Updated labels advise starting therapy in women younger than 60 or within 10 years of menopause. - Innovative Vitality offers local hormone therapies, including topical creams, implants and injections. - The practice also offers systemic therapy, including pills, systemic injections and implants. - Providers use each patient's health history, lab results, symptoms and lifestyle to choose treatment options. - Visits last 30 to 60 minutes and begin with a full review of health history and symptoms. - Treatment plans can combine hormone therapy, non-hormonal medications, supplements and lifestyle strategies. - The clinic monitors patients with quarterly bloodwork. - The program treats hot flashes, night sweats, sleep problems, brain fog, mood swings, low libido, vaginal dryness, weight gain, fatigue, and hair and skin changes. - Insurance is used for appointments and labs. - The menopause team is led by Renata Gazzi, MD, DABOM, MSCP, who is joined by Monica Medrano, MD; Meredith Villarreal, NP; Alexis Davidman, PA; and Arielle Douglas, PA.

Between the lines: - The release points to a mismatch between how common menopause is and how little clinical guidance many women receive. - The FDA label change may make hormone therapy feel more accessible, but the release suggests trust and awareness remain barriers. - Longer visits and repeated monitoring signal a more intensive model than many routine primary care appointments. - The clinic is positioning menopause care as a subspecialty need, not a standard issue women should manage on their own.

What's next: - Innovative Vitality is inviting women in Chicago and throughout Illinois to seek a discovery call. - The practice appears to be building awareness around menopause care as demand for treatment and education grows. - The clinic's telehealth option may expand access for patients outside Chicago but within Illinois.

The bottom line: - Innovative Vitality is trying to make menopause care more accessible, longer, and more personalized for women who have not gotten answers elsewhere.